# ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

> **NCT04744662** · PHASE1 · COMPLETED · sponsor: **ONL Therapeutics** · enrollment: 28 (actual)

## Conditions studied

- Geographic Atrophy

## Interventions

- **DRUG:** ONL1204 Ophthalmic solution
- **PROCEDURE:** sham injection

## Key facts

- **NCT ID:** NCT04744662
- **Lead sponsor:** ONL Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-08
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-02-29
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04744662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04744662, "ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04744662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*